INS and hyperlipidemia: Prevalent comorbidities included hypertension in 80 (43%) patients, hyperlipidemia in 58 (31%), diabetes treated with oral antidiabetic therapy in 44 (24%), and diabetes treated with insulin in 32 (17%).